Publication:
Prolonged use of low molecular weight heparin after PTCA results in a down-regulation of C-reactive protein and von Willebrand factor.

Simple item page
dc.contributor.authorsFareed, J; Jeske, WP; Walenga, JM; Hoppensteadt, DA; Uras, F; Demir, M
dc.date.accessioned2022-03-10T17:48:27Z
dc.date.accessioned2026-01-10T16:54:02Z
dc.date.available2022-03-10T17:48:27Z
dc.date.issued2000
dc.identifier.doidoiWOS:000087725600094
dc.identifier.issn0009-9147
dc.identifier.urihttps://hdl.handle.net/11424/220956
dc.identifier.wosWOS:000087725600094
dc.language.isoeng
dc.publisherAMER ASSOC CLINICAL CHEMISTRY
dc.relation.ispartofCLINICAL CHEMISTRY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleProlonged use of low molecular weight heparin after PTCA results in a down-regulation of C-reactive protein and von Willebrand factor.
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageA24
oaire.citation.issue6
oaire.citation.startPageA24
oaire.citation.titleCLINICAL CHEMISTRY
oaire.citation.volume46

Files

Collections

Araştırma Çıktıları